Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-653-9 | CAS number: 98-29-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- End of the study period: 25 August 1992
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- No long term treatment (exposure for 24h) was conducted in the absence of metabolic activation as recommended by the guideline OECD 473. Only short term treatments (3 h) with and without metabolic activation were conducted. Only 2 dose levels analysed for the genotoxicity had an acceptable cytotoxicity. The third dose analysed had a reduction of mitotic index by 80%.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- 4-tert-butylpyrocatechol
- EC Number:
- 202-653-9
- EC Name:
- 4-tert-butylpyrocatechol
- Cas Number:
- 98-29-3
- Molecular formula:
- C10H14O2
- IUPAC Name:
- 4-tert-butylbenzene-1,2-diol
Constituent 1
Method
Species / strain
- Species / strain / cell type:
- mammalian cell line, other: Chinese hamster ovary (CHO) cells
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 fraction of rats liver induced with Aroclor 1254 (= S9)
- Test concentrations with justification for top dose:
- 0, 2.5, 5, 7.5, 10 and 20 µg/mL
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: no data
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- other: methylmethanesulfonate (without S9); benzo(a)pyrene (with S9)
- Details on test system and experimental conditions:
- The assay using duplicate cultures was performed both with and without S9. A single sampling time was used: 24 hours, i.e. 1.5 cell cycle times from the beginning of treatment.
For each culture, approximately 5 x 10E5 cells were seeded in 3 mL DMEM (Eagle medium modified by Dulbecco) medium containing 10% fetal calf serum, 1% L. glutamine, penicillin, streptomycin and fungizon in flasks of 25 cm2. The flasks were then placed at 37°C in a humidified atmosphere of 5% CO2 in 95% air. After 24 hours, the cultures were exposed to the test subtance:
- for 3 hours at 37°C in culture medium without fetal calf serum for the assay without S9,
- for 3 hours at 37°C in the culture medium without fetal calf serum containing 15% S9, for the assay with S9.
After treatment, the cells were observed under a microscope to assess any morphological alterations, the treatment medium removed, the cells rinsed and fresh medium added. The cultures were then incubated for 21 hours at 37°C.
Two hours before cell collection, the cells were treated with a colcemid solution in order to stop mitosis at the metaphase-stage.
The cells were then rinsed, trypsinated, harvested and centrifuged. After a hypotonic treatment, they were fixed in a methanol/acetic acid mixture, spread on slides and stained with Giemsa. Two slides/culture were prepared. - Evaluation criteria:
- - a test substance was considered as clastogenic if, at one or more concentrations, it induced a statistically significant increase in the incidence of cells with aberrations. This increase should exceed the normal range of historical negative control data.
- a test substance was considered as non-clastogenic if there was no significant increase in cells with aberrations frequency at any doses, above concurrent control frquencies.
Evaluation of the results:
The mitotic index was evaluated for all the cultures. The chromosomal abnormalities were scored on the slides corresponding to 3 treated cultures which were selected according to the mitotic index and to all the controls. 200 metaphases/concentration were analysed whenever possible. The structural aberrations (chromatid and chromosomal gaps, deletions and exchanges and others (multiple aberrations and pulverizations)) were recorded for each metaphase. - Statistics:
- The incidence of cells wtih aberrations (excluding gaps) in treated cultures was compared to that of the solvent cultures using the "Chi-square" test.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- At 10 µg/mL and 20 µg/mL, a reduction of the mitotic index of 80% and 100% was observed, respectively. No significant reduction was noted at 7.5 µg/mL and below.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- At 10 and 20 µg/mL, a reduction of the mitotic index of 40% and 80% was observed, respectively. At 7.5 µg/mL and below, no significant reduction was observed.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Cytotoxicity:
The mitotic index was, as compared to the controls:
- without S9: reduced by 100% at 20 µg/mL, by 80% at 10 µg/mL, by 13% at 7.5 µg/mL, by 40% at 5 µg/mL and by 27% at 2.5 µg/mL;
- with S9: reduced by 80% at 20 µg/mL, by 40% at 10 µg/mL and similar to that of controls at the lower concentrations (by 0% at 7.5 µg/mL, by 20% at 5 µg/mL and by 27% at 2.5 µg/mL)
Genotoxicity:
The chromosomal abnormalities were scored on the slides corresponding to the 3 following concentrations:
- without S9: 2.5, 5 and 10 µg/mL
- with S9: 5, 10 and 20 µg/mL.
It should be noted that the dose levels of 10 µg/mL in the absence of metabolic activation, and 20 µg/mL in the presence of metabolic activation, showed a very severe cytotoxicity (reduction of the mitotic index of 80%). Indeed, these 2 tested dose levels should not have been selected for a reliable genotoxicity analysis. According to the recent guideline OECD 473, the highest tested concentration should achieve 55 ± 5% cytotoxicity using the recommended cytotoxicity parameters (i.e. reduction in Mitotic Index), and care should be taken in interpreting positive results only to be found in the higher end of this 55 ± 5% cytotoxicity range.
In addition, no analysis was conducted on the dose level of 7.5 µg/mL (probably because the mitotic index is the less reducted at this dose).
The absence of the analysis at the dose of 7.5 µg/mL did not affect the reliability of the study. The analysed dose range was narrow with a concentration interval of 2 fold between the analysed doses (2.5, 5 and 10 µg/mL without S9 mix and 5, 10 and 20 µg/mL with S9 mix). In addition, no cytotoxicity was observed at 7.5 µg/mL and below, and no genotoxicity was noted over the analysed range.
The analysis of the chromosomal aberrations gave the following results:
- With S9, the incidence of cells with aberrations in the cultures treated with TBC was similar to that of the negative controls, whatever the analysed dose.
- Without S9, at 2.5 and 5 µg/mL, the incidence of cells with aberrations was similar to that of the controls.
At 10 µg/mL, a statistically significant increase (p<0.05) was observed when compared to the solvent control and out of the the historical data. but this increase was not statistically significant when compared to the untreated cultures. In addition, as discussed above, this positive effect was observed at the dose level of 10 µg/mL showing a mitotic index reduced by 80%, i.e. very above the maximum cytotoxicity recommended by the guideline. This severe cytotoxicity of 80% does not allow a reliable genotoxicity analysis, and the genotoxicity analysis should not be considered.
Over the analysed range from 2.5 to 5 µg/mL (showing an acceptable cytotoxicity), no increase in the cells with aberrations was observed.
The incidence of cells with aberrations in the negative and solvent controls was within the range of the historical data.
The incidence of cells with aberrations in the positive controls was significantly higher (p<0.001) than that in the control cultures, indicating the sensitivity of the test system.
In conclusion, according to the recent guideline OECD 473 (adopted on 29 july 2016), no increase in the cells with aberrations was observed in the tested dose levels with an acceptable cytotoxicity, either in absence or in presence of metabolic activation. - Remarks on result:
- other: A weak positive effect was observed at 10 µg/mL. The cytotoxicity was very severe at this dose (reduction of the mitotic index by 80%). According to the recent guideline, this dose level should not have been selected for a reliable genotoxicity analysis.
Applicant's summary and conclusion
- Conclusions:
- Under the experimental conditions, 4-tert-butylpyrocatechol did not showed any increase in the chromosomal aberrations test performed in Chinese Hamster Ovary (CHO) cells treated up to the limit of an acceptable cytotoxicity and under an exposure time of 3 hours, either in the absence or in the presence of metabolic activation.
- Executive summary:
In a mammalian cell cytogenetics assay, CHO (Chinese Hamster Ovary) cell cultures were exposed for an exposure time of 3 hours to 4 -tert-butylpyrocatechol (TBC) (purity: 99%) in DMSO at concentrations of 0, 2.5, 5, 7.5, 10 and 20 µg/mL with and without metabolic activation (rat liver S9 fraction).
In the absence of metabolic activation, the test substance showed severe cytotoxic effects as evaluated by mitotic index which was reduced by 80% compared to the control at 10 µg/mL and by 100% at 20 µg/mL. The dose selected for the genotoxicity effect were 10, 5 and 2.5 µg/mL. At 10 µg/mL, a statistically significant increase was observed when compared to the solvent control and it was out of the the historical data.
But this increase was not statistically significant when compared to the untreated cultures. In addition, this positive effect was only observed at the dose level of 10 µg/mL showing a mitotic index reduced by 80%, i.e. very above the maximum cytotoxicity recommended by the guideline. This severe cytotoxicity of 80% does not allow to retain this tested dose for the genotoxicity analysis.
In absence of S9, the genotoxicity analysis over the range showing an acceptable cytotoxicity (2.5 to 5 µg/mL) did not show any increase in the cells with aberrations.
In the presence of metabolic activation, the test substance showed cytotoxic effects at 20 µg/mL as seen by a decrease in mitotic index of 80% compared to the control. The analysis of the clastogenic effect was done at 5, 10 and 20 µg/mL. No increase in the cells with aberrations was noted.
Positive controls induced the appropriate response.
This study is classified as acceptable. This study satisfies the requirement for Test Guideline OECD 473 for in vitro cytogenetic mutagenicity data (In vitro chromosomal analysis in CHO cells).
Under the experimental conditions, 4-tert-butylpyrocatechol did not showed any increase in the chromosomal aberrations test performed in Chinese Hamster Ovary (CHO) cells treated up to the limit of an acceptable cytotoxicity according to the recent guideline OECD 473, either in the absence or in the presence of metabolic activation after 3 hours of incubation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.